OrbiMed

China export industry and global supply chain Cargo airplane flying over logistic containers
Biotech

AirNexis swoops in with $200M series A for COPD asset

AirNexis has inked a deal potentially worth almost $1 billion with a China biopharma, securing rights to a clinical-stage COPD asset.
Gabrielle Masson Jan 9, 2026 11:01am
purple lightning tornado

Electra shines with $183M fundraise for rare disease trial

Oct 22, 2025 8:26am
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Barinthus enters reverse merger with metabolic disease biotech

Sep 30, 2025 10:39am
Sparrow flying from a tree branch

Sparrow flits forward with $95M for midstage diabetes asset

Sep 24, 2025 11:22am
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Sitala seals $670M deal for Fosun immune disease drug

Aug 26, 2025 2:44pm
red and purple piggy banks

OrbiMed gets $1.86B for latest fund despite 'challenging' market

Aug 4, 2025 10:25am